Our studies with PET imaging of 89Zr-CXCR4-mAb in subcutaneous and orthotopic mouse models of NSCLC verified that the variable uptake of the imaging agent was based on CXCR4 expression levels. This evidence concerns the gene CXCR4 and non-small cell lung carcinoma.